<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Indinavirsulfat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:00 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Indinavirsulfat_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Indinavirsulfat_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Indinavirsulfat_files/filelist.xml">
<title>INDINAVIR SULFAT</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-08-08T14:06:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:25:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1451</o:Words>
  <o:Characters>8277</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>68</o:Lines>
  <o:Paragraphs>19</o:Paragraphs>
  <o:CharactersWithSpaces>9709</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>INDINAVIR SULFAT<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>: Indinavir.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC</span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: J05A
E02.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c</span></b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>: Kháng retrovirus.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nang:
200 mg (tính theo indinavir).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viên
nén: 400 mg (tính theo indinavir).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
là ch&#7845;t &#7913;c ch&#7871; enzym protease c&#7911;a virus gây h&#7897;i
ch&#7913;ng suy gi&#7843;m mi&#7877;n d&#7883;ch &#7903; ng&#432;&#7901;i
(HIV), thu&#7889;c có tác d&#7909;ng m&#7841;nh và có kh&#7843; n&#259;ng ch&#7885;n
l&#7885;c cao. Tác d&#7909;ng c&#7911;a indinavir là &#7913;c ch&#7871;
protease ghi mã c&#7911;a HIV - 1 và HIV - 2. Enzym này c&#7847;n cho s&#7921;
phân chia các ti&#7873;n ch&#7845;t polypeptid &#273;&#7875; t&#7841;o ra các
protein c&#7845;u trúc và các enzym thi&#7871;t y&#7871;u c&#7911;a virus
&#273;ó bao g&#7891;m các enzym phiên mã ng&#432;&#7907;c, integrase và
protease. Các ch&#7845;t &#7913;c ch&#7871; protease ng&#259;n c&#7843;n s&#7921;
tr&#432;&#7903;ng thành c&#7911;a virus do &#273;ó có tác d&#7909;ng trên các t&#7871;
bào b&#7883; nhi&#7877;m b&#7879;nh c&#7845;p và mãn bao g&#7891;m các b&#7841;ch
c&#7847;u &#273;&#417;n nhân to và &#273;&#7841;i th&#7921;c bào th&#432;&#7901;ng
không b&#7883; các ch&#7845;t &#7913;c ch&#7871; enzym phiên mã ng&#432;&#7907;c
nhóm dideoxynucleosid tác &#273;&#7897;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
không tác &#273;&#7897;ng &#273;&#7871;n các giai &#273;o&#7841;n &#273;&#7847;u
c&#7911;a chu trình sao chép c&#7911;a HIV, tuy nhiên thu&#7889;c ng&#259;n c&#7843;n
và h&#7841;n ch&#7871; &#273;&#432;&#7907;c s&#7921; lan r&#7897;ng thêm c&#7911;a
virus &#7903; trong c&#417; th&#7875;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
là thu&#7889;c &#7913;c ch&#7871; &#273;&#7863;c hi&#7879;u cao trên protease c&#7911;a
HIV, &#7903; nh&#7919;ng n&#7891;ng &#273;&#7897; thích h&#7907;p trong lâm
sàng thu&#7889;c không &#7843;nh h&#432;&#7903;ng &#273;&#7871;n ho&#7841;t
tính các enzym c&#7911;a ng&#432;&#7901;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
ch&#7881; dùng indinavir m&#7897;t mình virus kháng thu&#7889;c s&#7869; phát
tri&#7875;n ngay trong vòng kho&#7843;ng m&#7897;t tháng, do &#273;ó trong
&#273;i&#7873;u tr&#7883; không bao gi&#7901; &#273;&#432;&#7907;c dùng
indinavir &#273;&#417;n l&#7867;. Ít có kh&#7843; n&#259;ng x&#7843;y ra kháng
chéo gi&#7919;a indinavir và các ch&#7845;t &#7913;c ch&#7871; enzym phiên mã
ng&#432;&#7907;c c&#7911;a HIV, vì các enzym &#273;ích c&#7911;a chúng khác
nhau. Có s&#7921; kháng chéo &#273;áng chú ý gi&#7919;a indinavir và ritonavir,
ch&#7845;t &#7913;c ch&#7871; protease. Kháng chéo gi&#7919;a indinavir và các
ch&#7845;t &#7913;c ch&#7871; protease khác c&#7911;a HIV c&#361;ng &#273;ã x&#7843;y
ra &#7903; nh&#7919;ng m&#7913;c &#273;&#7897; khác nhau.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
chuy&#7875;n hóa qua h&#7879; th&#7889;ng cytochrom P<sub>450</sub> &#7903; gan
và &#273;&#432;&#7901;ng tiêu hóa.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
có tác d&#7909;ng kháng virus m&#7841;nh trong lâm sàng, làm gi&#7843;m
&#273;&#432;&#7907;c l&#432;&#7907;ng RNA c&#7911;a virus trong huy&#7871;t
t&#432;&#417;ng 10 &#273;&#7871;n 100 l&#7847;n ngay trong giai &#273;o&#7841;n
&#273;i&#7873;u tr&#7883; &#273;&#7847;u tiên.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7875;
gi&#7843;m nguy c&#417; kháng thu&#7889;c, có th&#7875; dùng ph&#7889;i h&#7907;p
các ch&#7845;t &#7913;c ch&#7871; protease v&#7899;i các thu&#7889;c kháng
retrovirus khác (nh&#432; các nucleosid).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
dùng &#273;&#417;n l&#7867; ho&#7863;c ph&#7889;i h&#7907;p v&#7899;i các thu&#7889;c
kháng retrovirus khác không th&#7875; ch&#7919;a kh&#7887;i h&#7859;n
&#273;&#432;&#7907;c nhi&#7877;m HIV và &#273;i&#7873;u tr&#7883; b&#7857;ng
các thu&#7889;c này b&#7879;nh v&#7851;n có th&#7875; ti&#7871;p t&#7909;c ti&#7871;n
tri&#7875;n k&#7875; c&#7843; các nhi&#7877;m khu&#7849;n c&#417; h&#7897;i và
các bi&#7871;n ch&#7913;ng khác c&#7911;a b&#7879;nh AIDS. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
&#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
h&#7845;p thu nhanh theo &#273;&#432;&#7901;ng u&#7889;ng và &#273;&#7841;t n&#7891;ng
&#273;&#7897; &#273;&#7881;nh huy&#7871;t t&#432;&#417;ng trong 0,8 gi&#7901;.
Sinh kh&#7843; d&#7909;ng kho&#7843;ng 65% sau li&#7873;u duy nh&#7845;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7913;c
&#259;n &#7903; d&#7841; dày làm gi&#7843;m &#273;áng k&#7875; s&#7921; h&#7845;p
thu c&#7911;a indinavir khi u&#7889;ng, do &#273;ó nên dùng thu&#7889;c lúc
&#273;ói. B&#7919;a &#259;n giàu calo, protein ho&#7863;c ch&#7845;t béo có th&#7875;
làm gi&#7843;m h&#7845;p thu thu&#7889;c kho&#7843;ng 75%.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
chuy&#7875;n hóa &#7903; gan &#273;&#7875; cho 7 s&#7843;n ph&#7849;m chuy&#7875;n
hóa g&#7891;m 1 ch&#7845;t liên h&#7907;p glucuronid và 6 ch&#7845;t chuy&#7875;n
hóa oxy hóa. Nghiên c&#7913;u in vitro cho th&#7845;y cytochrom P<sub>450</sub>
là enzym chính c&#7847;n thi&#7871;t cho s&#7921; t&#7841;o thành các ch&#7845;t
chuy&#7875;n hóa oxy hóa.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
th&#7843;i tr&#7915; nhanh, n&#7917;a &#273;&#7901;i th&#7843;i tr&#7915; trong
huy&#7871;t t&#432;&#417;ng trung bình 1 gi&#7901; 48 phút. &#7903; ng&#432;&#7901;i
x&#417; gan và suy gan, kéo dài t&#7899;i 2 gi&#7901; 48 phút 30 phút. Thu&#7889;c
&#273;&#7841;t n&#7891;ng &#273;&#7897; th&#7845;p trong d&#7883;ch não - t&#7911;y.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
th&#7843;i tr&#7915; ch&#7911; y&#7871;u qua phân (&gt; 80%) và qua n&#432;&#7899;c
ti&#7875;u (&lt; 20%) &#7903; c&#7843; d&#7841;ng không bi&#7871;n &#273;&#7893;i
và d&#7841;ng chuy&#7875;n hóa.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ði&#7873;u
tr&#7883; nhi&#7877;m HIV. Thu&#7889;c luôn luôn &#273;&#432;&#7907;c dùng k&#7871;t
h&#7907;p v&#7899;i ít nh&#7845;t m&#7897;t thu&#7889;c kháng retrovirus khác
(phác &#273;&#7891; &#273;i&#7873;u tr&#7883; 2 thu&#7889;c, thí d&#7909;
indinavir - zidovudin) ho&#7863;c v&#7899;i 2 thu&#7889;c kháng retrovirus khác
[phác &#273;&#7891; &#273;i&#7873;u tr&#7883; 3 thu&#7889;c, thí d&#7909;
indinavir - lamivudin - zidovudin (ho&#7863;c stavudin)].<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá m&#7851;n
v&#7899;i indinavir.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>C&#7847;n
l&#432;u ý khi dùng cho ng&#432;&#7901;i b&#7883; suy gan, vì indinavir và các
thu&#7889;c t&#432;&#417;ng t&#7921; &#7913;c ch&#7871; protease c&#7911;a HIV
&#273;&#432;&#7907;c chuy&#7875;n hóa ch&#7911; y&#7871;u &#7903; gan. C&#7847;n
gi&#7843;m li&#7873;u cho nh&#7919;ng ng&#432;&#7901;i b&#7879;nh này. N&#7871;u
suy gan n&#7863;ng không nên dùng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7863;c
dù thu&#7889;c bài ti&#7871;t qua th&#7853;n t&#432;&#417;ng &#273;&#7889;i ít
nh&#432;ng ph&#7843;i u&#7889;ng &#273;&#7911; n&#432;&#7899;c &#273;&#7875;
tránh nguy c&#417; s&#7887;i th&#7853;n, ng&#432;&#7901;i b&#7879;nh suy ch&#7913;c
n&#259;ng th&#7853;n c&#7847;n &#273;&#432;&#7907;c theo dõi.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng th&#7853;n
tr&#7885;ng &#7903; ng&#432;&#7901;i &#273;ái tháo &#273;&#432;&#7901;ng vì các
thu&#7889;c &#7913;c ch&#7871; protease c&#7911;a HIV làm t&#259;ng glucose huy&#7871;t
và làm b&#7879;nh xu&#7845;t hi&#7879;n ho&#7863;c n&#7863;ng thêm lên.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
có th&#7875; làm t&#259;ng ch&#7843;y máu &#7903; ng&#432;&#7901;i b&#7883;
hemophili.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>L&#432;u
ý &#7903; ng&#432;&#7901;i b&#7883; &#7881;a ch&#7843;y n&#7863;ng, vì s&#7921;
h&#7845;p thu các thu&#7889;c &#7913;c ch&#7871; protease c&#7911;a HIV có th&#7875;
b&#7883; ng&#259;n c&#7843;n, do &#273;ó không &#273;&#7841;t &#273;&#432;&#7907;c
n&#7891;ng &#273;&#7897; &#273;i&#7873;u tr&#7883; trong máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
b&#7879;nh dùng indinavir c&#7847;n &#273;&#432;&#7907;c th&#7847;y thu&#7889;c
có kinh nghi&#7879;m theo dõi ch&#7863;t ch&#7869; và &#273;&#432;&#7907;c nh&#7855;c
nh&#7903; r&#7857;ng n&#7871;u th&#7845;y có b&#7845;t k&#7923; s&#7921; thay
&#273;&#7893;i nào v&#7873; tình tr&#7841;ng s&#7913;c kh&#7887;e thì ph&#7843;i
tìm &#273;&#7871;n các c&#417; s&#7903; &#273;i&#7873;u tr&#7883;. C&#7847;n bi&#7871;t
r&#7857;ng vi&#7879;c tr&#7883; li&#7879;u b&#7857;ng indinavir c&#361;ng không
làm gi&#7843;m &#273;&#432;&#7907;c nguy c&#417; lây truy&#7873;n HIV qua quan
h&#7879; tình d&#7909;c ho&#7863;c qua &#273;&#432;&#7901;ng máu và v&#7851;n
ph&#7843;i duy trì nh&#7919;ng bi&#7879;n pháp &#273;&#7873; phòng lây truy&#7873;n
HIV trong th&#7901;i gian tr&#7883; li&#7879;u v&#7899;i các thu&#7889;c kháng
retrovirus.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Vì
indinavir có kh&#7843; n&#259;ng làm t&#259;ng bilirubin huy&#7871;t và gây
&#273;&#7897;c v&#7899;i th&#7853;n &#7903; tr&#7867; s&#417; sinh, không nên
dùng thu&#7889;c này trong th&#7901;i k&#7923; mang thai.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ngày nay
&#273;&#7875; phòng s&#7921; lây truy&#7873;n HIV tr&#7921;c ti&#7871;p t&#7915;
m&#7865; sang tr&#7867; s&#417; sinh ch&#7881; có zidovudin là thu&#7889;c
kháng retrovirus &#273;&#432;&#7907;c khuyên dùng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7863;c
dù còn ch&#432;a bi&#7871;t indinavir có ti&#7871;t vào s&#7919;a m&#7865; hay
không nh&#432;ng do thu&#7889;c có th&#7875; gây ra nh&#7919;ng ph&#7843;n &#7913;ng
ph&#7909; nguy hi&#7875;m cho tr&#7867; &#273;ang bú m&#7865;, ng&#432;&#7901;i
m&#7865; dùng indinavir không nên cho con bú. H&#417;n n&#7919;a do kh&#7843;
n&#259;ng lây truy&#7873;n HIV cho nh&#7919;ng tr&#7867; nh&#7887; ch&#432;a b&#7883;
b&#7879;nh nên ng&#432;&#7901;i ta v&#7851;n khuyên m&#7865; b&#7883; nhi&#7877;m
HIV không nên cho con bú, m&#7863;c dù có dùng thu&#7889;c kháng retrovirus hay
không.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Bu&#7891;n
nôn, nôn, &#273;au b&#7909;ng, &#7881;a ch&#7843;y, &#273;&#7855;ng mi&#7879;ng,
m&#7879;t m&#7887;i, &#273;au &#273;&#7847;u, choáng váng, n&#7893;i ban da, ng&#7913;a,
suy ch&#7913;c n&#259;ng th&#7853;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>&#7906;
chua, khó tiêu, khô mi&#7879;ng, gi&#7843;m c&#7843;m giác, m&#7845;t ng&#7911;,
khó ti&#7875;u ti&#7879;n, khô da và t&#259;ng nhi&#7877;m s&#7855;c, t&#259;ng
glucose huy&#7871;t, s&#7887;i th&#7853;n, suy th&#7853;n, h&#7897;i ch&#7913;ng
Stevens - Johnson.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hi&#7871;m
g&#7863;p, ADR &lt; 1/1000</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'><o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7843;n
&#7913;ng d&#7883; &#7913;ng (&#273;ôi khi là ph&#7843;n &#7913;ng ph&#7843;n v&#7879;),
ti&#7875;u ti&#7879;n ra máu, thi&#7871;u máu c&#7845;p do tan máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Viêm gan
(&#7903; ng&#432;&#7901;i b&#7879;nh dùng indinavir ph&#7889;i h&#7907;p v&#7899;i
các thu&#7889;c kháng retrovirus khác), vàng da.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng và cách dùng <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong
&#273;i&#7873;u tr&#7883; HIV, indinavir &#273;&#432;&#7907;c dùng ph&#7889;i h&#7907;p
v&#7899;i các thu&#7889;c &#7913;c ch&#7871; enzym phiên mã ng&#432;&#7907;c c&#7911;a
nucleosid. Ph&#7843;i u&#7889;ng thu&#7889;c ít nh&#7845;t 1 gi&#7901; tr&#432;&#7899;c
ho&#7863;c 2 gi&#7901; sau khi &#259;n. C&#7847;n u&#7889;ng &#273;&#7911;
n&#432;&#7899;c (ít nh&#7845;t là 1,5 lít/ngày). Có th&#7875; ph&#7843;i ng&#7915;ng
&#273;i&#7873;u tr&#7883; n&#7871;u có &#273;&#7907;t s&#7887;i th&#7853;n c&#7845;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
dùng c&#7911;a indinavir sulfat &#273;&#432;&#7907;c tính theo indinavir. Li&#7873;u
khuy&#7871;n cáo cho ng&#432;&#7901;i l&#7899;n là 800 mg/l&#7847;n; cách 8 gi&#7901;
u&#7889;ng m&#7897;t l&#7847;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
suy gan nh&#7865; ho&#7863;c trung bình do x&#417; gan dùng li&#7873;u 600 mg/l&#7847;n;
cách 8 gi&#7901; u&#7889;ng m&#7897;t l&#7847;n.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
tác thu&#7889;c <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Indinavir
và các thu&#7889;c t&#432;&#417;ng t&#7921; &#7913;c ch&#7871; protease c&#7911;a
HIV &#273;&#432;&#7907;c chuy&#7875;n hóa ch&#7911; y&#7871;u nh&#7901;
cytochrom P<sub>450</sub>. Chúng th&#432;&#7901;ng c&#7841;nh tranh v&#7899;i
nhi&#7873;u thu&#7889;c c&#361;ng &#273;&#432;&#7907;c chuy&#7875;n hóa theo
cùng m&#7897;t con &#273;&#432;&#7901;ng, nên th&#432;&#7901;ng làm n&#7891;ng
&#273;&#7897; c&#7911;a các thu&#7889;c trong huy&#7871;t t&#432;&#417;ng cùng
t&#259;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng
&#273;&#7891;ng th&#7901;i indinavir v&#7899;i astemizol, cisaprid, midazolam,
terfenadin và triazolam có th&#7875; làm gi&#7843;m chuy&#7875;n hóa và
t&#259;ng n&#7891;ng &#273;&#7897; trong huy&#7871;t t&#432;&#417;ng c&#7911;a
các thu&#7889;c này do tranh ch&#7845;p cytochrom P<sub>450</sub> và có kh&#7843;
n&#259;ng gây ra các tác d&#7909;ng ph&#7909; nguy hi&#7875;m nh&#432; ch&#7913;ng
lo&#7841;n nh&#7883;p tim, nhi&#7877;m &#273;&#7897;c th&#7847;n kinh và các
&#273;&#7897;c tính khác. Do &#273;ó ch&#7889;ng ch&#7881; &#273;&#7883;nh dùng
&#273;&#7891;ng th&#7901;i indinavir và các thu&#7889;c trên.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh dùng &#273;&#7891;ng th&#7901;i indinavir và
rifampicin vì rifampicin là ch&#7845;t gây c&#7843;m &#7913;ng m&#7841;nh cho
cytochrom P<sub>450</sub> và do &#273;ó có th&#7875; làm gi&#7843;m n&#7891;ng
&#273;&#7897; indinavir trong huy&#7871;t t&#432;&#417;ng xu&#7889;ng d&#432;&#7899;i
m&#7913;c có tác d&#7909;ng &#273;i&#7873;u tr&#7883;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng
&#273;&#7891;ng th&#7901;i indinavir (800 mg, cách 8 gi&#7901; m&#7897;t l&#7847;n)
và rifabutin (300 mg/ngày) trong 10 ngày &#273;ã làm gi&#7843;m di&#7879;n tích
d&#432;&#7899;i &#273;&#432;&#7901;ng cong c&#7911;a n&#7891;ng &#273;&#7897;
thu&#7889;c trong huy&#7871;t t&#432;&#417;ng bi&#7871;n thiên theo th&#7901;i
gian (AUC) c&#7911;a indinavir 32% và làm t&#259;ng AUC c&#7911;a rifabutin lên
204%, do &#273;ó nên gi&#7843;m 50% li&#7873;u rifabutin n&#7871;u dùng cùng v&#7899;i
indinavir.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng
&#273;&#7891;ng th&#7901;i indinavir (li&#7873;u duy nh&#7845;t 400 mg) và
ketoconazol (li&#7873;u duy nh&#7845;t 400 mg) s&#7869; làm t&#259;ng AUC c&#7911;a
indinavir 68%, do &#273;ó nên gi&#7843;m li&#7873;u dùng c&#7911;a thu&#7889;c &#7913;c
ch&#7871; protease c&#7911;a HIV xu&#7889;ng 600 mg/l&#7847;n, cách 8 gi&#7901;
u&#7889;ng m&#7897;t l&#7847;n &#7903; ng&#432;&#7901;i b&#7879;nh &#273;ang
&#273;i&#7873;u tr&#7883; v&#7899;i ketoconazol.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7863;c
dù indinavir &#273;&#432;&#7907;c dung n&#7841;p t&#7889;t khi dùng cùng v&#7899;i
thu&#7889;c &#7913;c ch&#7871; enzym phiên mã ng&#432;&#7907;c
dideoxynucle-osid, nh&#432;ng dùng &#273;&#7891;ng th&#7901;i indinavir v&#7899;i
zidovudin có th&#7875; làm t&#259;ng t&#7881; l&#7879; m&#7897;t s&#7889; tác d&#7909;ng
ph&#7909; nh&#7845;t &#273;&#7883;nh (nh&#432; suy nh&#432;&#7907;c, m&#7879;t
m&#7887;i, bu&#7891;n nôn, nôn, &#273;au &#273;&#7847;u, choáng váng) so v&#7899;i
khi dùng thu&#7889;c &#273;&#417;n l&#7867;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
dùng indinavir &#273;&#7891;ng th&#7901;i v&#7899;i didanosin, ph&#7843;i u&#7889;ng
cách xa nhau.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trong
khi pH acid có th&#7875; c&#7847;n cho s&#7921; h&#7845;p thu t&#7889;i &#432;u
c&#7911;a indinavir thì didanosin l&#7841;i b&#7883; phân h&#7911;y nhanh &#7903;
pH acid. Do &#273;ó ph&#7843;i u&#7889;ng các thu&#7889;c này cách xa nhau ít
nh&#7845;t m&#7897;t gi&#7901; và c&#7843; 2 thu&#7889;c ph&#7843;i &#273;&#7873;u
u&#7889;ng lúc &#273;ói.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng
&#273;&#7891;ng th&#7901;i indinavir và nevirapin có th&#7875; làm gi&#7843;m n&#7891;ng
&#273;&#7897; indinavir trong huy&#7871;t t&#432;&#417;ng vì nevirapin là ch&#7845;t
gây c&#7843;m &#7913;ng cytochrom P<sub>450</sub>, do &#273;ó c&#7847;n xem xét
t&#259;ng li&#7873;u indinavir cho ng&#432;&#7901;i l&#7899;n lên 1000 mg/l&#7847;n,
cách 8 gi&#7901; u&#7889;ng m&#7897;t l&#7847;n &#7903; ng&#432;&#7901;i b&#7879;nh
&#273;ang dùng nevirapin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Dùng
&#273;&#7891;ng th&#7901;i indinavir và delavirdin s&#7869; làm t&#259;ng n&#7891;ng
&#273;&#7897; &#273;&#7881;nh huy&#7871;t t&#432;&#417;ng và AUC c&#7911;a
indinavir vì delavirdin &#7913;c ch&#7871; chuy&#7875;n hóa c&#7911;a
indinavir. Do &#273;ó c&#7847;n xem xét gi&#7843;m li&#7873;u indinavir cho
ng&#432;&#7901;i l&#7899;n xu&#7889;ng 600 mg/l&#7847;n, cách 8 gi&#7901; u&#7889;ng
m&#7897;t l&#7847;n &#7903; ng&#432;&#7901;i b&#7879;nh ph&#7843;i &#273;i&#7873;u
tr&#7883; &#273;&#7891;ng th&#7901;i 2 thu&#7889;c này.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7843;o
qu&#7843;n nang indinavir sulfat n&#417;i khô &#7903; nhi&#7879;t &#273;&#7897;
t&#7915; 15 - 30<sup>0</sup>C trong các chai l&#7885; nút kín và có thêm ch&#7845;t
hút &#7849;m.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá
li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
gây ch&#7871;t c&#7845;p c&#7911;a indinavir cho ng&#432;&#7901;i còn ch&#432;a
&#273;&#432;&#7907;c bi&#7871;t. Các li&#7873;u duy nh&#7845;t u&#7889;ng ho&#7863;c
&#273;&#432;a vào trong màng b&#7909;ng l&#7899;n g&#7845;p 10 &#273;&#7871;n
20 l&#7847;n li&#7873;u &#273;i&#7873;u tr&#7883; &#7903; ng&#432;&#7901;i
&#273;ã không gây ch&#7871;t cho chu&#7897;t nh&#7855;t ho&#7863;c chu&#7897;t
l&#7899;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Các bi&#7875;u
hi&#7879;n quá li&#7873;u indinavir ch&#7911; y&#7871;u là kéo dài các ph&#7843;n
&#7913;ng không mong mu&#7889;n c&#7911;a thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u
x&#7843;y ra quá li&#7873;u c&#7845;p thì c&#7847;n ti&#7871;n hành &#273;i&#7873;u
tr&#7883; h&#7895; tr&#7907;, &#273;i&#7873;u tr&#7883; tri&#7879;u ch&#7913;ng
và theo dõi ch&#7863;t ch&#7869; ng&#432;&#7901;i b&#7879;nh. Vì còn ch&#432;a
bi&#7871;t vi&#7879;c th&#7849;m tách th&#7853;n nhân t&#7841;o và th&#7849;m
tách màng b&#7909;ng có th&#7875; lo&#7841;i tr&#7915; &#273;&#432;&#7907;c
indinavir hay không, không nên dùng bi&#7879;n pháp này &#273;&#7875; t&#259;ng
th&#7843;i tr&#7915; thu&#7889;c kh&#7887;i c&#417; th&#7875;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Indinavirsulfat.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:00 GMT -->
</html>
